Abstract:Objective: To explore the prognostic factors of malignant melanoma patients. Methods: The clinical data and treatment protocol of 64 patients with malignant melanoma were collected. All patients were followed up for 2 years and then the data were analyzed. The survival rate was calculated by KaplanMeier method, the survival curve was drawn by Logrank method and the survival rate of each group was compared. Results: The mean age of onset was 62 years, the 1year and 2year survival rates were 80.6% and 35.4%, respectively. Tumor location, ulceration, lymph node metastasis, surgical types were significantly associated with 2year survival rate, but effects of age, sex, pain, postoperative radiotherapy, chemotherapy or biological immunotherapy on survival rates were not clear. Conclusion: Tumors occur in the mucosa or not identified, early lymph node metastasis and tumors ulceration were significantly associated with poor prognosis.
收稿日期: 2017-03-01
通讯作者:
李遇梅(通讯作者).主任医师,E-mail: l.yumei@aliyun.com
作者简介: 王莹(1989—),女,硕士研究生
引用本文:
王莹, 黄建玲, 刘莉萍, 许辉, 李遇梅. 恶性黑色素瘤临床特征及治疗方式与预后的相关分析[J]. 江苏大学学报:医学版, 2017, 27(5): 428-431.
WANG Ying, HUANG Jian-ling, LIU Li-ping, XU Hui, LI Yu-mei. Clinical characteristics and treatment of malignant melanoma and its prognosis analysis. Journal of Jiangsu University(Medicine Edition), 2017, 27(5): 428-431.
[1\]Jemal A, Siegel R, Xu J, et al. Cancer statistics,2010\[J\]. CA Cancer J Clin, 2010, 60(5): 277-300.\[2\]曾红梅, 张思维, 郑荣寿, 等. 2003~2007年中国皮肤黑色素瘤发病与死亡分析\[J\]. 中国肿瘤, 2012, 21(3): 183-189.\[3\]CSCO黑色素瘤专家委员会. 中国黑色素瘤诊治指南(2011版)\[J\]. 临床肿瘤学杂志, 2012, 17(2): 159-171.\[4\]Callender GG, Egger ME, Burton AL, et al. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker\[J\]. Am J Surg, 2011, 202(6): 659-664.\[5\]BirchJohansen F, Hvilsom G, Kjaer T, et al. Social inequality and incidence of and survival from malignant melanoma in a populationbased study in Denmark, 1994-2003\[J\]. Eur J Cancer, 2008, 44(14): 2043-2049.\[6\]Strmberg U, Holmén A, Peterson S. Spatial disparities in melanoma incidence and prognosis with consideration to stage at diagnosis, gender and marital status\[J\]. Spat Spatiotemporal Epidemiol, 2016, 19: 21-27.\[7\]迟志宏, 盛锡楠, 李思明, 等. 357例中国皮肤黑色素瘤临床特征与预后分析\[J\]. 肿瘤防治研究, 2011, 38(11): 1316-1319.\[8\]Xu X, Chen L, Guerry D, et al. Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma\[J\]. Clin Cancer Res, 2012, 18(1): 229-237.\[9\]Eggermont AM, Spatz A, Lazar V, et al. Is ulceration in cutaneous melanoma just a prognostic and predictive factor or is ulcerated melanoma a distinct biologic entity?\[J\]. Curr Opin Oncol, 2012, 24(2): 137-140.\[10\]Morton DL. Overview and update of the phase Ⅲ Multicenter Selective Lymphadenectomy Trials (MSLTⅠ and MSLTⅡ) in melanoma\[J\]. Clin Exp Metastasis, 2012, 29(7): 699-706.\[11\]Kaufman HL, Kirkwood JM, Hodi FS, et al. The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma\[J\]. Nat Rev Clin Oncol, 2013, 10(10): 588-598.\[12\]庞得全, 郑维国, 胡雷,等. 恶性黑色素瘤预后影响因素的Cox分析\[J\]. 山东医药, 2011, 51(12):89-91.\[13\]李曙光, 黎莉. 93例转移性恶性黑色素瘤预后分析\[J\]. 中国肿瘤临床, 2004, 31(8): 446-448.\[14\]王亚丽, 石光跃, 龚海燕, 等. 333例恶性黑色素瘤患者的预后相关因素分析\[J\]. 现代肿瘤医学, 2014, 22(2): 444-447.